← Back to all trials
Active Not Recruiting
NCT07316088
Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms
Conditions: PTSD, Post Traumatic Stress Disorder
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE2
Enrollment: 40
Sponsor: Oui Therapeutics, Inc.
Location: Florida State University Tallahassee Florida
Summary
This study is exploring the efficacy of a digital therapeutic app in reducing symptoms of posttraumatic stress disorder (PTSD) in adults.
Eligibility Criteria
Inclusion Criteria:
* Posttraumatic stress disorder (PTSD) diagnosis
* Anxiety Sensitivity Index 3 (ASI-3) scores above 24
* PTSD Checklist for DSM-V (PCL-5) scores above 30
* Understands and speaks English
* Access to a smartphone that is connected to the internet
Exclusion Criteria:
* Score of 24 or lower on the ASI-3
* Score of 30 and below on the PCL-5
* No PTSD diagnosis
* Active psychosis
* Acute intoxication during study baseline
* Enrolled in another treatment research study
* Medical illness that would prevent the completion of interoceptive exposure exercises
Source: ClinicalTrials.gov (NCT07316088). StuddyBuddy aggregates publicly available trial information.
